CorBec Pharmaceuticals Inc., InKine, Panax, Sangen Pharmaceutical Co. deal

PANX completed its previously announced stock acquisitions of Sangen and CorBec (see BioCentury, Jan. 27 and May 12). CorBec shareholders received an upfront payment of $750,000 and 750,000 shares of ...